Chargement en cours...
Poor glycemic control might compromise the efficacy of chemotherapy in non‐small cell lung cancer patients with diabetes mellitus
BACKGROUND: Previous studies indicated that type 2 diabetes mellitus (T2DM) is related to an increased lung cancer risk, but its role in the prognosis of NSCLC remains conflicting. This study investigated the impact of blood glucose control on the outcomes in NSCLC patients with T2DM treated with pl...
Enregistré dans:
| Publié dans: | Cancer Med |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
John Wiley and Sons Inc.
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6997083/ https://ncbi.nlm.nih.gov/pubmed/31830375 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.2750 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|